Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy

Ähnliche Einträge

• Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
  von: Inoue, Kenji, et al.
  Veröffentlicht: (2014)
• Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
  von: Inoue, Kenji, et al.
  Veröffentlicht: (2012)
• Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
  von: Nakakura, Shunsuke, et al.
  Veröffentlicht: (2012)
• Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies
  von: Hamacher, T, et al.
  Veröffentlicht: (2004)
• Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from β-blockers and prostaglandin analogs
  von: Inoue, Kenji, et al.
  Veröffentlicht: (2012)